What to Know About Bixlenvo for HIV

By Meaghan Lee Callaghan What do you know about the newly approved HIV combination drug bictegravir/lenacapavir (Bixlenvo, Gilead)?Following the new FDA approval, Onyema Ogbuagu, MBBCh, MD, a professor at Yale University, in New Haven, sat down with Infectious Disease Special Edition to talk about the drug. Dr. Ogbuagu, who is also the director of the Yale Antivirals and Vaccines Research Program (formerly HIV Clinical Trials program), should know best—he was a study investigator